# Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma

> **NCT01711177** · NA · COMPLETED · sponsor: **Université de Montréal** · enrollment: 14 (actual)

## Conditions studied

- Primary Open Angle Glaucoma

## Interventions

- **DRUG:** placebo
- **DRUG:** travoprost

## Key facts

- **NCT ID:** NCT01711177
- **Lead sponsor:** Université de Montréal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711177, "Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01711177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*